Israel made ‘significant breakthrough’ in developing antibody against coronavirus:…
Defense Minister Bennett visited the labs of the Israel’s Institute for Biological Research (IIBR), supervised by the Prime…
Author
Gujarat hospitals to join WHO’s ‘Solidarity’ clinical trial
The trial, to be conducted by the Indian Council of Medical Research (ICMR), at hospitals in Ahmedabad, Vadodara, Surat and…
Loadshare Networks raises Rs 100 crore to fund expansion
The startup will utilise the funds to expand its network and make a foray into new sectors like pharmaceuticals, fast-moving…
Alembic Pharma gets VAI classification from USFDA for Panelav facility
The US FDA inspection was conducted from March 9-13, 2020
Enough medicine stocks available, avoid panic buying: AICDA
Purchases should be made on doctor's prescription, advises AICDA President
Laurus Labs’ PAT touches Rs 110 crore in Q4
The consolidated revenue for the quarter was up by 32 per cent to Rs 839 crore as against Rs 635 crore in Q4 FY'19, a press…
Cadila Healthcare to sell stake in Windlas Healthcare to Windlas Biotech for Rs 99.44 cr
The sale is expected to be completed within 10 business days
Serum Institute plans to price coronavirus vaccine at ₹1,000 if trials succeed
Serum decided to start manufacturing it as it had shown success in animal trials
Glenmark gets tentative USFDA approval for generic anti-diabetes tablets
The approval is for the strength of 10 mg/5 mg tablets
Natco Pharma gets USFDA approval for Visakhapatnam facility
The company did not disclose the product approved by the USFDA to be produced from the facility